Overview
Closing in on Post-Thrombotic Syndrome: The Latest Updates
PTS Touchpoint
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Dr. Kush Desai from Northwestern Medicine and Dr. Erin Murphy from Sanger Heart and Vascular, Atrium Health discuss the latest updates in post-thrombotic syndrome (PTS) including a review on the newer venous stents as well as limitations with conservative therapies in this targeted 30-minute CME touchpoint. The touchpoint features images, easy-to-read charts and graphs, and features their expert perspectives on the treatment of PTS, the benefits of venous stenting, as well as the best follow-up approach in patients in post-stenting.
Featured topic areas include:
• Risk assessment of PTS
• Non-procedural vs procedural PTS care
• Latest clinical trial data with the venous stents
• Case-based applications for practice
This activity is intended for interventional cardiologists, interventional radiologists, vascular surgeons, and other healthcare clinicians interested in treating patients with venous disease.
Because non-procedural interventions continue to be overutilized over procedural care for PTS, clinicians need to better understand the drawbacks with non-procedural strategies. Clinicians need to be aware that strategies such as with the newer venous stents have been shown to be safe and effective with outcomes such as improving venous disease-related quality of life and ulcer healing. It is also critical for clinicians to be able to distinguish among the several venous stents available as they differ in device ramifications and clinical trial data. Lastly, it is important for clinicians to know which intervention (non-procedural, procedural, etc.) is best for their patients with PTS based on individual characteristics and disease severity. Once clinicians overcome these knowledge gaps, they will be better able to ensure the optimal use of venous stents and guarantee the best outcomes for their patients with PTS.
Upon completion of this activity, participants will be able to:
• Indicate the role and limitations of conservative therapies (medications and compression stockings) for PTS
• Evaluate the currently available stenting platforms indicated for the treatment of deep venous obstruction
• Identify optimal deep and superficial treatment options for patients with PTS based on patient symptoms and pathophysiology
• Indicate the role and limitations of conservative therapies (medications and compression stockings) for PTS
• Evaluate the currently available stenting platforms indicated for the treatment of deep venous obstruction
• Identify optimal deep and superficial treatment options for patients with PTS based on patient symptoms and pathophysiology
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Boston Scientific Corporation.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
5. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Kush Desai, MD, FSIR
Associate Professor of Radiology, Surgery, and Medicine
Division of Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, IL
Associate Professor of Radiology, Surgery, and Medicine
Division of Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, IL
Erin Murphy, MD
Director of the Venous and Lymphatic Institute
Sanger Heart and Vascular, Atrium Health
Charlotte, NC
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Kush Desai, MD, FSIR (Faculty)
Advisor or Review Panel Member: Boston Scientific Corporation, Cardinal Health, Medtronic, Philips, Tactile Medical
Grant/Research Support Recipient: Boston Scientific Corporation
Consultant: Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Cook Medical, W. L. Gore & Associates, Medtronic, Philips, Shockwave Medical, Tactile Medical
Speakers' Bureau: Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical, Medtronic, Tactile Medical
Erin Murphy, MD (Faculty)
Advisor or Review Panel Member: Boston Scientific Corporation, Medtronic, Philips
Consultant (Occasional): Boston Scientific Corporation, Cordis Corporation, Medtronic, Philips, W. L. Gore & Associates
Speakers' Bureau: Boston Scientific Corporation, Medtronic, Philips
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)
This enduring material initially launched on March 29, 2021. The content was re-reviewed for scientific validity and accuracy on February 16, 2022 and April 7, 2023. Accreditation for this activity will expire on March 29, 2024.
